Market Cap: Private
- Real-time solution that provides better medical outcomes, increases diagnostic certainty, early identification of complications and replaces x-rays with harmless Sonar. Fewer demands and costs on an overburdened Medical System while saving Patients and Medical Staff time, disrupting the current standard of care.
- Current demand and interest from medical and insurance communities with ability to use existing reimbursement codes. Completed human surrogate models and live animal trials correlating with human bone trauma. Addresses the mandates from FDA and Health Canada to use less radiation. A multi-revenue solution with a proven and experienced team and rapid commercialization. Strategic partners with FDA & ISO design, engineering, and manufacturing registrations. Matching government grants and Investor-friendly deal structure.